CHIRON REAL ESTATE INC (XRN)
Real Estate · Healthcare real estate investment trust · NYSE
Chiron Real Estate is an internally managed REIT focused on acquiring and leasing decentralized medical office buildings and specialized healthcare facilities to physician groups and healthcare systems.
What CHIRON REAL ESTATE INC does
Chiron Real Estate Inc. (formerly Global Medical REIT Inc.) is an internally managed REIT that acquires and owns healthcare properties leased primarily to physician groups and regional/national healthcare systems under triple-net leases. As of December 31, 2025, the company owned 189 buildings with approximately 5.1 million leasable square feet generating annualized base rent of $118.8 million. The portfolio is concentrated in off-campus medical office buildings (79.1% of square footage), inpatient rehabilitation facilities, and surgical hospitals, with geographic focus on secondary markets and suburbs of primary markets.
Themes: healthcare real estate, medical office buildings, physician group leasing, healthcare systems tenants, secondary market healthcare facilities, REIT dividends, decentralized healthcare delivery
Fundamentals
- Price$37.15 as of 2026-08-21 close
- Market cap$492M as of 2026-08-21
- 1-year return+6.1% 2025-08-21 close $35.00 → 2026-08-21 close $37.15
- P/En/a negative earnings
- Net margin-5.1% as of 2026-08-24
- ROE-1.5% as of 2026-08-24
- Debt / equity1.33 as of 2026-08-24
- Revenue growth (YoY)+9.7% as of 2026-08-24
- Revenue CAGR (3y)+2.6% SEC XBRL
- Beta1.16 as of 2026-08-24
- Last reported earnings2026-08-05 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +9.0%; at least 5 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How XRN compares in its sector
- net profit marginbottom 25% 161 covered Real Estate peers, as of 2026-08-24
- operating marginbottom 25% 161 covered Real Estate peers, as of 2026-08-24
- return on equitybottom 25% 162 covered Real Estate peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 155 covered Real Estate peers
- indicated dividend yieldtop 25% 138 covered Real Estate peers, as of 2026-08-24
Position among covered Real Estate companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, XRN's dividend was covered by reported results (operating-cash-flow payout 8%). This describes past coverage, not a forecast.
- Earnings payoutnot assessable earnings not reported
- Operating-cash-flow payout8% dividends / operating cash flow — capital spending was not reported, so this does not subtract it
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How CHIRON REAL ESTATE INC looks technically
CHIRON REAL ESTATE INC (XRN) is trading 5.8% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 138 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 10, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 56, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 7 trading days ago (its momentum flipped positive). It made a new 20-day low about 13 trading days ago.
Trend
8
| Distance from the 200-day | it is trading 5.8% above its 200-day average, the long-term trend line — a longer-term uptrend | +5.8% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $36.58 | $36.58 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $35.10 | $35.10 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing high 7 calendar days ago — the swings before that are what the structure reading is measured on | 7 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five; the labelling fails if price closes above 37.67. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a three-part correction in leg C. | possible downward five-wave sequence, in wave 3 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 138 trading days ago — a "golden cross", a bullish long-term signal | 138 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 10, below the 25 that marks a real trend) | 9.6 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 56, neither overbought (above 70) nor oversold (below 30) | 56.0 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($34.50 to $37.67) — its "stochastic" reading is 84 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 83.6 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 7 trading days ago (its momentum flipped positive) | 7 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $39.93 | $39.93 |
|---|---|---|
| From the 52-week high | it is 7.0% below its 52-week high (its highest price of the past year) | -7.0% |
| Above the 52-week low | it is 27.9% above its 52-week low (its lowest price of the past year) | +27.9% |
| Below the 52-week high | it is 7.0% below its highest point of the past year | 7.0% |
| Since a 20-day breakout | it made a new 20-day low about 13 trading days ago | 13 sessions |
| Since a 55-day breakout | it made a new 55-day high about 36 trading days ago | 36 sessions |
| All-time high | its highest closing price on record is $92.55 (set on 2022-01-04) | $92.55 |
| Given back of the 52-week move | over the past year its closes ranged ($30.15 to $38.65), and it has recovered almost all of its fall from last year’s high — 82% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $35.40 to $35.67. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 82.3% |
| From the all-time high | it is 59.9% below its all-time high | -59.9% |
| Nearest price level | it is trading 1.4% below a resistance level at $37.69 — a price it turned at six times since 2024-12-30, most recently on 2026-08-14. Since 2024-08-21 it has 7 such levels below the current price and 7 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +1.4% |
| All-time low | its lowest closing price on record is $29.05 (set on 2025-11-05) | $29.05 |
| Above the all-time low | it is 27.9% above its all-time low | +27.9% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are narrower than usual versus its own recent 6-month history (tighter than about 76% of it) | 24th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $1.03 between its high and its low — about 2.8% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $1.03 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $34.65 and $37.77 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $34.65 – $36.21 – $37.77 |
| Typical daily range (% of price) | its price moves about 2.8% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.8% |
| Stretch from the 200-day average | it is trading 2.0 daily ranges above its 200-day average price (5.8% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 2.0 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.97× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Price gaps
3
| Gap at the open | it opened on 2026-08-21 0.9% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.9% |
|---|---|---|
| Open gap | it gapped 3.9% above the previous close 7 sessions ago and has not traded back through the level it left behind at 35.1 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +3.9% |
| Gap filled | a 2.1% gap up opened on 2026-08-14 has been "filled" 4 sessions ago — price traded back through the level the gap left behind, and it took 1 session to close | 4 sessions ago |
Price streaks
1
| Closing streak | it has closed higher 3 sessions in a row, a +2.88% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 3 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 4.4 percentage points (the stock lost 2.0% while the market gained 2.3%) | -4.4% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 3.9 percentage points (the stock lost 0.8% while the market gained 3.1%) | -3.9% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 7.8 percentage points (the stock gained 3.3% while the market gained 11.1%) | -7.8% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 14.3 percentage points (the stock gained 6.1% while the market gained 20.5%) | -14.3% |
Signal agreement
2
| Bullish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, MACD momentum is positive, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 4 of 9 |
|---|---|---|
| Bearish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bearish state: lagging the market over 6 months, near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 2 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 0.6% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-15 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is thick, spanning 8.3% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | +0.6% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 5% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $35.37 — a volume-weighted average of daily closes over 159 sessions, not a true tick-by-tick VWAP. | +5.0% |
|---|---|---|
| Vs the average paid since it last reported | the price is 3% above the average price paid since it last reported on 2026-08-05 (its 8-K), so the typical buyer over that stretch is showing a gain. That average is $36.20 — a volume-weighted average of daily closes over 13 sessions, not a true tick-by-tick VWAP. | +2.6% |
Price levels it has turned at before
XRN last closed at $37.15 on 2026-08-21. Since 2024-08-21 it has turned at 7 prices below its last close and 7 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $37.69 | Resistance | 1.4% above the last close | turned there six times · 2024-12-30 to 2026-08-14 |
| $36.20 | Support | 2.6% below the last close | turned there 10 times · 2025-01-10 to 2026-07-10 |
| $38.57 | Resistance | 3.8% above the last close | turned there four times · 2025-02-03 to 2026-07-17 |
| $34.64 | Support | 6.8% below the last close | turned there four times · 2026-04-24 to 2026-08-05 |
| $39.74 | Resistance | 7.0% above the last close | turned there twice · 2025-04-28 to 2025-09-22 |
| $33.79 | Support | 9.1% below the last close | turned there three times · 2025-04-11 to 2026-03-02 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five.
This labelling fails — stops being a possible reading at all — if it closes above $37.67.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $31.31 and $33.74 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a three-part correction in leg C, which fails on a close above $37.67.
This reading has stood for 1 trading day, since 2026-08-21.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · trendless / choppy (low ADX) · lagging the market · At the top of its 14-day range (stochastic above 80) · Trading above the Ichimoku cloud · Near a resistance level (pressing into a price that has capped it before) | Learn: moving average · golden cross · adx · rsi · macd · breakout
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (2.40 mean, 1=Strong Buy…5=Strong Sell) — 8 analysts
- Mean price target$38.00 range $9.00 – $46.00; median $41.50
Analyst estimates, as of 2026-08-18. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for XRN
- Consensus EPS estimate-$0.85 next reporting period, as of 2026-08-18
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Geographic concentration in six states (Texas, Florida, Ohio, Arizona, Pennsylvania, Illinois) exposes the company to regional economic downturns and natural disasters that could negatively affect revenues.","Tenant credit quality and healthcare sector cyclicality risks; failure of physician groups or healthcare system tenants to meet lease obligations would impact rental revenue and profitability.","Interest rate and refinancing risk; the company carries significant debt (credit facility of $662.3 million as of March 31, 2026) and relies on leverage to fund acquisitions, making it vulnerable to rising rates and refinancing challenges."]
What changed in the latest 10-Q
AI-assisted comparison of XRN's 10-Q filed 2026-05-07 against the prior one filed 2025-11-05.
Management's Discussion & Analysis (MD&A)
The two filings could not be meaningfully compared for this section.
Risk Factors
The two filings could not be meaningfully compared for this section.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
8 open-market purchases and 0 open-market sales by insiders in the last 90 days.
- Last 30 days8 buys ($3M) · 0 sells — 4 buying insiders
- Last 90 days8 buys ($3M) · 0 sells — 4 buying insiders
- Last 180 days21 buys ($3M) · 0 sells — 12 buying insiders
Cluster buying: 9 different insiders reported open-market purchases (SEC code P) of XRN within a 30-day window between 2026-05-11 and 2026-05-14. Disclosed Form 4 activity, not a prediction of performance or a buy signal.
Activity heuristic: net buying (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-17. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about XRN's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Short interest (FINRA)
XRN had 825,466 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
XRN had 6.24% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 11.35 days to cover at the same settlement.
- Reported short interest (shares) 825,466
- Short interest (% of shares outstanding) 6.24%
- Prior settlement (shares) 820,891
- Reported change 0.56%
- Days to cover (reported) 11.35
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Physicians Realty Trust (DOC)
- Welltower Inc. (WELL)
- Healthcare Trust, Inc. (HTIA)
- CNL Healthcare Properties
- Whitestone REIT
- Medical Properties Trust
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare XRN vs…
CHIRON REAL ESTATE INC is found in…
Frequently asked questions
What does CHIRON REAL ESTATE INC (XRN) do?
Chiron Real Estate Inc. (formerly Global Medical REIT Inc.) is an internally managed REIT that acquires and owns healthcare properties leased primarily to physician groups and regional/national healthcare systems under triple-net leases. As of December 31, 2025, the company owned 189 buildings with approximately 5.1 million leasable square feet generating annualized base rent of $118.8 million.
What sector is CHIRON REAL ESTATE INC (XRN) in?
CHIRON REAL ESTATE INC (XRN) is classified in the Real Estate sector. Its industry is Healthcare real estate investment trust. It trades on NYSE.
Does XRN pay a dividend?
Yes — CHIRON REAL ESTATE INC (XRN) pays a dividend, with an indicated yield of about 8.98% and at least 5 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-08-24). Informational only — not financial advice.
Who are CHIRON REAL ESTATE INC's (XRN) competitors?
Notable peers of CHIRON REAL ESTATE INC (XRN) include Physicians Realty Trust, Welltower Inc., Healthcare Trust, Inc., CNL Healthcare Properties and Whitestone REIT. This peer set is informational only — not financial advice.
Is CHIRON REAL ESTATE INC (XRN) overbought or oversold right now?
CHIRON REAL ESTATE INC (XRN) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 56, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on XRN come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.